Sten Estrup will assume new role on the 1st October 2019.
In a press release, Biomega – which produces hydrolyzed salmon proteins (salmon peptides), salmon meal and salmon oil – wrote that Estrup comes with 25 years’ experience across the food and health industry in executive roles in operations, sales, marketing and commercial development.
Estrup joins Biomega Group from a position as Executive Vice President of Asia Pacific & Latin America at Chr. Hansen, a leading bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries.
“I am honoured to join Biomega and work with the team, partners, customers and the owner AMERRA to release the true potential of Biomega’s leading technology for human grade ingredients. The world of food production and agriculture is waiting for Biomega’s technology and expertise to help improve productivity and produce more with less”, said Estrup. “Biomega is well positioned to leverage the emerging demand for natural science-backed bioactive peptides to the nutraceutical and functional food industry”, Estrup added.
In agreement with Jørgen Horntvedt, the former CEO, Horntvedt has stepped down and will pursue other opportunities outside of Biomega. Thomas Samdal, the CFO of Biomega Group, has taken on the role as interim CEO until Estrup commences the position.
